Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PZAKY | OVV |
|---|---|---|
| Price | $19.46 | $60.95 |
| Change today | ▲ 0.00% | ▲ 1.01% |
| Market cap | $16.80B | $16.79B |
| Return, 3 months | +8.7% | +11.4% |
| Return, year to date | +19.1% | +57.9% |
| Return, 1 year | +15.7% | +55.6% |
| P/E (TTM) | 9.4 | 17.0 |
| P/B | 0.5 | 1.5 |
| P/E percentile vs own 5y | – | 77th |
| Dividend yield | 6.55% | 1.97% |
| Revenue growth (YoY, latest qtr) | – | +30.0% |
| Net profit growth (YoY) | – | +48.5% |
| Gross margin | – | 59.5% |
| Operating margin | – | 27.6% |
| Net margin | – | 9.4% |
| Return on equity | – | 8.4% |
| Analyst target vs. price | – | +22.7% |
| Analyst buy share | – | 89% |
| RSI (14) | 47 | 48 |
| 30-day volatility | 52.1% | 32.2% |
| Max drawdown, 1 year | -28.4% | -17.1% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
